Bottom

Print Add to favorites
 

Company Name: Union Carbide Corp.
Public Availability Date: February 5, 1999

Document Sections:

LETTER OF INQUIRY
APPENDIX
STAFF REPLY LETTER

[LETTER OF INQUIRY]

December 4, 1998

Securities and Exchange Commission

Office of Chief Counsel

Division of Corporation Finance

450 Fifth Street, N.W.

Washington, D.C. 20549

Re: Union Carbide CorporationShareholder Proposal

of State of Wisconsin Investment Board

Ladies and Gentlemen:

Pursuant to Rule 14a-8(j) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), Union Carbide Corporation, a New York corporation (the "Company"), hereby gives notice of its intention to exclude from the proxy statement and form of proxy for the Company's 1999 annual meeting of stockholders (together, the "Proxy Materials") the proposal submitted by the State of Wisconsin Investment Board ("SWIB") by letter to the Company from Kurt N. Schacht, Chief Legal Counsel of SWIB (the "Proposal"). A copy of that letter, dated November 9, 1998, is attached hereto as Exhibit A. A copy of this letter and the supporting opinion of counsel are also being sent to SWIB.

The Company plans to file definitive copies of the Proxy Materials on March 17, 1999. Pursuant to Rule 14a-8(j), this notice has been filed with the Securities and Exchange Commission (the "Commission") before December 27, 1998.

The Proposal

The Proposal reads in its entirety as follows:

Shareholder Resolution

Union Carbide Corporation

WHEREAS, Union Carbide Corporation (the Company) through its Board of directors, has adopted a shareholder rights plan, dated July 26, 1989; and

WHEREAS, such shareholder rights plan is expiring on August 31, 1999; and

WHEREAS, the Board of Directors has the authority to adopt a new shareholder rights plan or amend or rescind the existing plan;

NOW THEREFORE, BE IT RESOLVED:

Pursuant to the authority of shareholders to change bylaws, the following bylaw shall be added to the Bylaws of Union Carbide Corporation: Treatment of Shareholder Rights Plans. The Board of Directors shall not change the expiration date of the shareholder rights plan or adopt any new shareholder rights plan, without the approval of such actions by the holders of a majority of the issued and outstanding shares. This bylaw may be repealed or amended only by the affirmative vote of a majority of the issued and outstanding shares. Further, any amendment to the current shareholder rights plan extending the expiration date and any new shareholder rights plan adopted by the Board of Directors after November 9, 1998, are hereby repealed and rescinded as of the date this bylaw is adopted.

The by-law proposed for adoption under the Proposal (the "Proposed By-Law") would prohibit the Board of Directors of the Company (the "Board") from (i) changing the expiration date of the Rights Agreement, dated as of July 26, 1989, as amended and restated as of May 27, 1992, and further amended as of December 3, 1996 (the "Rights Plan"), between the Company and Chase Mellon Shareholder Services Inc., as Rights Agent, or (ii) adopting a new shareholder rights plan, in each case without shareholder approval. In addition, the Proposed By-Law would rescind or repeal any amendment extending the expiration of the Rights Plan, or any new rights plan, adopted after November 9, 1998.

The Company believes, and has received the opinion of its counsel, Wachtell, Lipton, Rosen & Katz, attached as Exhibit B, that the Proposed By-Law (a) is invalid under the New York Business Corporation Law (the "NYBCL") and (b) if implemented, could cause the Company to violate New York law. Therefore, the Company believes the Proposal is excludable from its Proxy Materials under Rule 14a-8(i)(1) and Rule 14a-8(i)(2) under the Exchange Act.

Basis for Exclusion of the Proposal under Rule 14a-8

Rule 14a-8(i)(1) under the Exchange Act provides that a registrant may exclude a shareholder proposal from its proxy statement and form of proxy "if the proposal is not a proper subject for action by shareholders under the laws of the jurisdiction of the company's organization." Rule 14a-8(i)(2) under the Exchange Act provides that a registrant may exclude a shareholder proposal from its proxy statement and form of proxy "if the proposal would, if implemented, cause the company to violate any state, federal, or foreign law to which it is subject."

I The Proposed By-Law is Invalid Under the NYBCL

Section 601 of the NYBCL grants shareholders of New York corporations the authority to adopt by-laws only if such by-laws are not inconsistent with the NYBCL or the corporation's certificate of incorporation.1 It is a fundamental tenet of New York corporation law that a shareholder-adopted by-law that is inconsistent with the NYBCL is invalid. See, e.g., Joseph Polchinski Company v. Cemetery Floral Company, Inc., 433 N.Y.S.2d 825 (N.Y. App. Div. 1980); Benintendi y. Kenton Hotel, Inc., 294 N.Y. 112 (1945). Thus, "when bylaws adversely affect or limit statutory rights specifically conferred upon ... directors, they are invalid." 2 Isidore Kantrowitz & Sol Slutsky, White On New York Corporations 601.03 (13th ed. 1998) (hereinafter, "White On New York Corporations").

New York corporation law, like that of most states, operates under the premise that the management of the corporation shall be the responsibility of the board of directors. Section 701 of the NYBCL grants the board of directors of a New York corporation broad managerial authority over the corporation, stating that: "... the business of a corporation shall be managed under the direction of its board of directors."

Unlike the corporate laws of some states, New York statutory law also specifically provides for the creation of shareholder rights plans, and for their administration, by the board of directors. The Proposed By-Law would prohibit the Board from changing the expiration date of the Rights Plan, or adopting a new shareholder rights plan, without shareholder approval. Thus, it is squarely inconsistent with the NYBCL's specific grant to the Board of authority to adopt and administer a shareholder rights plan. Section 505(a)(1) of the NYBCL provides that:

Except as otherwise provided in this section or in the certificate of incorporation, a corporation may create and issue, whether or not in connection with the issue and sale of any of its shares or bonds, rights or options entitling the holders thereof to purchase from the corporation, upon such consideration, terms and conditions as may be fixed by the board, shares of any class or series . . . . (emphasis supplied).

Section 505(a)(2) provides that:

In the case of a domestic corporation that has a class of voting stock registered with the Securities and Exchange Commission pursuant to section twelve of the Exchange Act, the terms and conditions of such rights or options may include, without limitation, restrictions or conditions that preclude or limit the exercise, transfer or receipt of such rights or options by an interested shareholder [i.e., a 20% or greater shareholder] or any transferee of such interested shareholder or that invalidate or void such rights or options held by any such interested shareholder or any such transferee.

Section 505 makes clear that a limitation on the authority of a board of directors with respect to shareholder rights plans (other than any limitation contained in Section 505 itself) may not be contained in the by-laws, but must, instead, be contained in the certificate of incorporation. For the convenience of the Staff, the full text of Section 505 of the NYBCL is attached to this letter as Exhibit C.

The "Legislative Findings and Declaration" accompanying a 1988 amendment to Section 505(a) confirms the legislative intent to place decision-making with respect to shareholder rights plans in the hands of the corporation's board of directors:

Boards of directors of New York corporations must be accorded sufficient time to evaluate offers or bids made by any party for all or part of the shares of the corporation . . . . [T]he ability to [control the] receipt by certain shareholders . . . of rights or options created by the board of directors . . . will grant additional time to the board of directors to evaluate such offers or bids and take appropriate action thereafter . . . . It is the policy of this state to provide the board of directors reasonable opportunity to evaluate and respond to such offers.2

Section 505(a)(2)(ii) of the NYBCL reinforces the plain meaning of the words in Section 505(a)(1). Section 505(a)(2)(ii) specifically provides that the proper forum for challenging determinations of the board of directors with respect to shareholder rights plans is in a court proceeding. Section 505(a)(2)(ii) provides that:

Determinations of the board of directors whether to impose, enforce or waive or otherwise render ineffective [the] limitations or conditions [of the shareholder rights plan]... shall be subject to judicial review in an appropriate proceeding in which the courts formulate or apply appropriate standards in order to insure that such limitations or conditions are imposed, enforced or waived in the best long-term interests and short-term interests of the corporation and its shareholders considering, without limitation, the prospects for potential growth, development, productivity and profitability of the corporation.

In other words, the statutory scheme expressly recognizes that the determination of whether to implement, amend or redeem a shareholder rights plan is a question to be left to the business judgment of the board of directors of a New York corporation, subject to review by a court applying fiduciary duty standards.

An additional illustration of the statutory scheme is found in Section 505(d) of the NYBCL. Section 505(d) provides that "the issue of such rights or options to one or more directors, officers or employees of the corporation ... as an incentive to service or continued service with the corporation ... shall be authorized by a majority of the votes cast at a meeting of shareholders by the holders of shares entitled to vote thereon, or authorized by and consistent with a plan adopted by such vote of shareholders." Thus, in addition to any limitations that may be contained in the certificate of incorporation, Section 505(d) mandates that the authority of the board of directors to adopt and administer incentive stock option plans under Section 505(a)(1) be subject to shareholder approval. Section 505(d) illustrates that, where the legislature intended to impose a shareholder approval requirement on the issuance of rights or options, it knew how to do so. In contrast, the adoption and administration of a shareholder rights plan under Section 505 is left to the authority of the board of directors, subject only to any restriction set forth in the certificate of incorporation. As such, Section 505 "continues the New York policy of requiring shareholder approval for options granted to employees [and directors and officers] ..., but not requiring shareholder approval for rights or options granted to others." White on New York Corporations 505.01 (emphasis supplied). If the New York legislature intended that the authority of the board of directors with respect to shareholder rights plans should be limited by a shareholder approval requirement not contained in the certificate of incorporation, it would have provided for such an additional limitation in Section 505, as it did with respect to incentive stock option plans in Section 505(d).

Also relevant to the statutory scheme is Section 717 of the NYBCL, which provides that in exercising its business judgment, the board of directors is entitled to consider interests other than those of the shareholders. As the NYBCL explicitly allows directors to consider the interests of a number of other constituencies (e.g., the corporation's current and retired employees, its customers and creditors and the community in which it does business), it would be inconsistent with the statutory scheme to allow one constituency (i.e., the shareholders), however important that constituency is, to unilaterally prohibit actions by the board of directors that could dramatically affect all of the constituencies that the board of directors may consider.

The Proposed By-law, by prohibiting the Board from adopting a new rights plan and declaring a dividend of rights without shareholder approval, would also be inconsistent with the fundamental principle of New York corporation law that, under Section 510 of the NYBCL, the board of directors has the sole discretion to declare dividends, absent any limitations set forth in the certificate of incorporation. See, e.g., Kennedy v. Kennedy, 91 N.Y.S.2d 294, 304 (N.Y. Sup. Ct. 1949) ("The declaration of dividends rests in the uncoerced discretion of the board of directors at the time of the declaration or refusal to declare."); Hastings v. International Paper Co., 175 N.Y.S.2d 815, 819 (N.Y. App. Div. 1919) ("The directors alone may say when, how and to what extent dividends are to be paid.").

II The Proposed By-Law Could Require the Company to Violate New York Law

The Proposed By-Law would also rescind or repeal any amendment extending the expiration of the Rights Plan, or any new rights plan, adopted after November 9, 1998 but before effectiveness of the Proposed By-Law. The Company believes these provisions of the Proposed By-Law are invalid under New York law not only for the reasons discussed above, but also for the following reasons.

Assuming the Board were to adopt a new rights plan similar to the Rights Plan, the provisions of the Proposed By-Law rescinding such action by the Board would in effect allow the shareholders to reverse a lawful action of the Board. Such a "retroactive" shareholder-adopted by-law has been held to be inconsistent with the NYBCL. In Ripley v. Storer, a New York trial court invalidated, as inconsistent with the predecessor provision to NYBCL Section 701, a shareholder-adopted by-law providing that certain bonuses awarded to directors of the corporation previously approved by the board would be invalid and unenforceable unless ratified by the shareholders. Ripley v. Storer, 139 N.Y.S.2d 786 (Sup. Ct. 1955). In finding the proposed by-law inconsistent with the NYBCL, the court observed that "[b]y-laws are laws for the regulation of the business of the corporation, and I think it essential that they be legislative rather than judicial in character, that is, that they shall make rules for future action rather than pronounce judgment upon things that now exist." Id. at 795.

As noted above, Section 505(a) of the NYBCL authorizes the Board to adopt a shareholder rights plan and to declare a dividend of rights. The declaration and payment of this dividend is valid pursuant to New York law. In the event the Board were to adopt a new rights plan, as it clearly has the power to do, the provisions of the Proposed By-Law rescinding such adoption would cause the Company to rescind a lawfully declared dividend and, thereby, violate New York law. See, e.g., Wertheim Schroder & Co. Inc. v. Avon Products, Inc., No. 91 Civ. 2287, 1993 U.S. Dist. Lexis 6184, *21 (S.D.N.Y. April 1, 1993) (under New York Law, once board declares a dividend, company has legally binding obligation to pay dividend and dividend cannot be rescinded).

The Commission has recognized, in previous no-action letters, that a proposed mandatory by-law rescinding an existing shareholder rights plan would, if implemented, cause the corporation to rescind a dividend in violation of state law. See, e.g., SmithKline Beckman Corp. (available February 10, 1989) (Pennsylvania law) and The Upjohn Company (available March 19, 1987) (Delaware law). Therefore, in those cases, the Commission determined that there was a basis to exclude such proposals under the predecessor provisions to Rule 14a-8(i)(2) under the Exchange Act. Id.

Court Decisions in Other Jurisdictions Are Consistent with the Company's View

The Company is not aware of any court decision with respect to the validity of a by-law such as the Proposed By-Law under New York Law. The Company is aware, however, of two court decisions finding mandatory by-laws relating to shareholder rights plans invalid under the laws of Pennsylvania and Georgia, respectively. The Company is also aware of a court decision finding a mandatory by-law with respect to a shareholder rights plan valid under Oklahoma law. The Oklahoma case has been appealed to the U.S. Court of Appeals for the 10th Circuit, which has certified the question to the Oklahoma Supreme Court. The Company believes that the relevant corporate laws of New York with respect to this type of by-law are more similar to the laws of Pennsylvania and Georgia than to the laws of Oklahoma.

In the Pennsylvania case, the federal district court, applying Pennsylvania law, invalidated a by-law attempting to remove from the board of directors authority over a corporation's shareholder rights plan.3 The AMP court held that the Pennsylvania law provision expressly granting to the board of directors exclusive authority to adopt shareholder rights plans, absent a contrary provision in the certificate of incorporation, prohibited the shareholders from taking away that authority through a by-law amendment.4 Given that the Pennsylvania statute, like the NYBCL, has (i) a provision expressly granting to the board of directors exclusive authority to adopt shareholder rights plans, absent a contrary provision in the certificate of incorporation, and (ii) a provision allowing directors to consider constituencies other than shareholders in the exercise of their business judgment in connection with a corporate change of control, the Company believes the AMP decision is of precedential value in New York and is likely to be persuasive to a New York court.

In the Georgia case, the federal district court, applying Georgia law, invalidated a by-law that would have required the board of directors of Healthdyne Technologies to amend the corporation's shareholder rights plan so that it could be redeemed by the board even in the event a new slate of directors was elected.5 The Invacare court held that such a by-law violated a provision of Georgia law expressly granting to the board of directors authority to set the terms of rights issued under a shareholder rights plan.6 The Invacare court noted that "[t]he Official Comment to O.C.G.A. § 14-2-624(c) reveals that the board of directors' discretion to set the conditions of a rights plan is limited only by their fiduciary obligations to the corporation."7 This is similar to the 1988 Legislative History with respect to the amendments to Section 505(a) of the NYBCL, which contemplates that the authority of the board of a New York corporation in implementing and making determinations under a shareholder rights plan is subject only to the limitations set forth in the certificate of incorporation and judicial review of the board's actions.

In contrast, a federal district court in Oklahoma, applying Oklahoma law, upheld the validity of a by-law that, among other things, would prohibit the board of directors from adopting a shareholder rights plan without shareholder approval.8 Although the Oklahoma statute contains a provision similar to NYBCL 505(a)(1) authorizing the issuance of rights and options, it does not contain any provisions similar to NYBCL 505(a)(2) expressly validating shareholder rights plans and expressly giving the board authority to make determinations under rights plans subject only to court review. In addition, Oklahoma law does not contain provisions similar to NYBCL 717, allowing a board to consider non-shareholder constituencies. As noted above, the Fleming decision is on appeal. The Oklahoma federal district court was apparently, at least in part, influenced by the policy argument that shareholders should have a right of review over board of director decision-making with respect to a corporate change of control. In light of the explicit provisions in the NYBCL allowing directors to make determinations with respect to a rights plan subject only to court review, and allowing directors to consider constituencies other than shareholders in a change of control context, the Company believes a New York court is not likely to be persuaded by such a policy argument. For these reasons, to the extent decisions applying the laws of other jurisdictions would be relevant to a New York court, the decisions in AMP and Invacare have more relevance than the Fleming decision.

Conclusion

In sum, for the reasons set forth above, the Company believes the Proposed By-Law is invalid under New York law and, if implemented, could cause the Company to violate New York law. Therefore, the Company believes the Proposal is excludable from the Company's Proxy Materials under Rule 14a-8(i)(1) and Rule 14a-8(i)(2) under the Exchange Act.

Please feel free to call the undersigned at (203) 794-6327 with questions or requests for additional information. Should the Staff disagree with our conclusion, we would appreciate the opportunity to confer with the Staff before the issuance of its Rule 14a-8 response.

Sincerely yours,

-----FOOTNOTES-----

1 Section 601(b) provides that "[t]he by-laws may contain any provision relating to the business of the corporation, the conduct of its affairs, its rights or powers or the rights and powers of its shareholders, directors or officers, not inconsistent with this chapter...." (emphasis supplied).

2 See Section 1 of L. 1988, c. 743, eff. Dec. 21, 1988.

3 AMP Inc. v. Allied Signal Inc., No. Civ. 98-4405 (E.D. Pa. October 8, 1998) (Order) (hereinafter, "AMP").

4 Id. at 12-13.

5 Invacare Corp. v. Healthdyne Technologies, Inc., 968 F. Supp. 1578 (N.D. Ga. 1997) (hereinafter, "Invacare").

6 Id. at 1581-82.

7 Id. at 1582.

8 International Brotherhood of Teamsters General Fund v. Fleming Companies, Inc., No. Civ. 96-1650-A (W.D. Okla. Jan. 24, 1997) (Order) (hereinafter, "Fleming").

[APPENDIX]

Shareholder Resolution

Union Carbide Corporation

WHEREAS, Union Carbide Corporation (the Company) through its Board of directors, has adopted a shareholder rights plan, dated July 26, 1989; and

WHEREAS, such shareholder rights plan is expiring on August 31, 1999; and

WHEREAS, the Board of Directors has the authority to adopt a new shareholder rights plan or amend or rescind the existing plan;

NOW THEREFORE, BE IT RESOLVED:

Pursuant to the authority of shareholders to change bylaws, the following bylaw shall be added to the Bylaws of Union Carbide Corporation.: Treatment of Shareholder Rights Plans. The Board of Directors shall not change the expiration date of the shareholder rights plan or adopt any new shareholder rights plan, without the approval of such actions by the holders of a majority of the issued and outstanding shares. This bylaw may be repealed or amended only by the affirmative vote of a majority of the issued and outstanding shares. Further, any amendment to the current shareholder rights plan extending the expiration date and any new shareholder rights plan adopted by the Board of Directors after November 9, 1998, are hereby repealed and rescinded as of the date this bylaw is adopted.

SUPPORTING STATEMENT

If the shareholder rights plan ("poison pill") is not designed properly, the poison pill may be used to block offers that are in the best interests of the shareholders. Therefore, adoption or renewal of the poison pill should be conditioned on shareholder approval. Further, shareholders should have the opportunity to vote periodically on the continuation of the poison pill.

We believe that the current Union Carbide Corporation shareholder rights plan dated July 26, 1989 is not designed properly. Companies extending their poison pills should adopt a new type of poison pill that allows shareholder the opportunity to hold a referendum on any offer to acquire control of the company. If shareholder vote that the offer is in their best interests, the Board of Directors would be required to stop using the pill to block the offer. Meanwhile, there would be ample time for the Board to develop superior alternatives for shareholders.

This bylaw would have the effect of requiring the Company's Board of Directors to seek stockholder approval before renewing the existing poison pill or adopting a new poison pill. If the Board of Directors unilaterally extends the expiration date of the existing poison pill, or adopts a new plan before this bylaw is adopted, the bylaw would repeal such action by the Board.


[STAFF REPLY LETTER]

February 5, 1999

Response of the Office of Chief Counsel

Division of Corporation Finance

Re: Union Carbide Corporation

Incoming letter dated December 4, 1998

The revised proposal amends Union Carbide's bylaws to prohibit the board from changing the expiration date of its shareholder rights plan or adopting any new shareholder rights plan, without shareholder approval.

We are unable to concur in your view that Union Carbide may exclude the revised proposal under rule 14a-8(e)(2). Accordingly, we do not believe that Union Carbide may omit the revised proposal from its proxy materials in reliance on rule 14a-8(e)(2).

We note that your counsel and the proponent's counsel have cited Sections 505, 510, 601, 701 and 717 of the New York Business Corporation Law as potentially controlling the implementation of the revised proposal. However, neither counsel for you nor the proponent has opined as to any compelling state law precedent. In view of the lack of any decided legal authority we have determined not to express any view with respect to the application of rules 14a-8(i)(1) and 14a-8(i)(2) to the revised proposal.

Sincerely,

Carolyn Sherman

Special Counsel

Top


Clear Gif